Regulatory & Legal

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.

With final funding secured, Microporous is set to begin construction on a massive Virginia plant, a key step in strengthening America's EV supply chain.

As threats to GPS mount, NAL Technologies' new ultra-low power ALTM-T module offers a resilient timing solution for power grids and financial markets.

A new imaging agent could slash the years-long diagnostic delay for endometriosis, offering hope to millions of women suffering from the debilitating condition.

Facing a steep revenue drop, High Arctic banks on a new contract, diversification into rentals and fire services, and the promise of PNG's massive LNG project.

A new platform is launching AI-powered interviews and scheduling at a fraction of the cost of enterprise tools, promising to change how businesses hire.

Former HHS Secretary Tommy Thompson joins Vector Science & Therapeutics, leveraging his political clout to advance a novel transdermal drug delivery platform.

ProPetro posts a Q1 loss due to weather but reveals a massive power generation expansion with Caterpillar, betting big on data centers and microgrids.

New research challenges long-held beliefs, revealing a high-risk subset in "safe" tumors and a surprising link between body weight and cancer recurrence.

Arizona Metals' new study reveals a project with marginal returns at base prices but massive potential, hinging on a $609M investment and market upside.

Taiwanese firm Smart Power System unveils an AI-driven strategy to build disaster-proof microgrids and export its advanced energy technology worldwide.

Aker Solutions posts solid Q1 results with a massive order intake, rewarding shareholders while strategically pivoting towards emerging markets like nuclear energy.

A landmark A$3.9 billion deal takes Australia's wealth giant Insignia Financial private, signaling a new era for the nation's superannuation sector.

The company marks a pivotal transition from developer to producer, commencing leaching at its flagship Argentine project and setting sights on major growth.

China's mobile charging giant has completed its merger, leaving the public market. What's next for the firm in a landscape of intense competition?

The insurer's Q1 net income surged 33% on a booming insurance unit, while it strategically trims its reinsurance book amid a softening market.

Despite a Q1 net loss driven by a massive duty charge, the wood products giant shows operational resilience amid housing market and geopolitical pressures.

Singaporean oil trader Delixy Holdings faces a 180-day deadline to rescue its Nasdaq listing after its stock price collapsed, forcing tough choices.

Strong Q1 2026 earnings beat expectations, funding TETRA's strategic move into domestic lithium, bromine, and battery tech amid geopolitical shifts.

A new Humble facility producing advanced composite utility poles promises hundreds of jobs and a more resilient power grid for the storm-prone Gulf Coast.